These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19144806)

  • 1. High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest.
    Fernández-Mazarrasa C; Mazarrasa O; Calvo J; del Arco A; Martínez-Martínez L
    J Clin Microbiol; 2009 Mar; 47(3):827-9. PubMed ID: 19144806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC.
    Torrico M; González N; Giménez MJ; Alou L; Sevillano D; Navarro D; Díaz-Antolín MP; Larrosa N; Aguilar L; Garcia-Escribano N
    J Clin Microbiol; 2010 Jun; 48(6):2243-6. PubMed ID: 20351208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of different Mueller-Hinton agars and media age on Etest susceptibility testing of tigecycline.
    Tan TY; Ng LS; Chen DM
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):93-5. PubMed ID: 20727479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines.
    Hope R; Warner M; Mushtaq S; Ward ME; Parsons T; Livermore DM
    J Antimicrob Chemother; 2005 Dec; 56(6):1042-6. PubMed ID: 16286361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp.
    Thamlikitkul V; Tiengrim S
    J Antimicrob Chemother; 2008 Oct; 62(4):847-8. PubMed ID: 18567913
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility testing of tigecycline against Acinetobacter spp. by disc diffusion method: withdrawing a therapeutic option by varying the Mueller-Hinton agar?
    Canigia LF; Bantar C
    J Antimicrob Chemother; 2008 Dec; 62(6):1463-4. PubMed ID: 18782779
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.
    Wang P; Bowler SL; Kantz SF; Mettus RT; Guo Y; McElheny CL; Doi Y
    J Clin Microbiol; 2016 Dec; 54(12):2937-2941. PubMed ID: 27629901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on: Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp.
    Curcio D; Fernández F
    J Antimicrob Chemother; 2008 Nov; 62(5):1166-7. PubMed ID: 18689874
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of daptomycin Etest MICs on Mueller Hinton, IsoSensitest and brain heart infusion agars from Europe against 20 Staphylococcus aureus isolates.
    Koeth LM; DiFranco JM
    Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1261-4. PubMed ID: 20567868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates.
    Ricciardi R; Ricciardi AM; Danzi G
    Infez Med; 2009 Dec; 17(4):236-9. PubMed ID: 20046104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Etest to determine tigecycline MICs for Enterobacter species.
    Cohen Stuart J; Mouton JW; Diederen BM; Al Naiemi N; Thijsen S; Vlaminckx BJ; Fluit AC; Leverstein-van Hall MA
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2746-7. PubMed ID: 20350941
    [No Abstract]   [Full Text] [Related]  

  • 12. [Variability in the sensitivity to tigecycline against Acinetobacter baumannii in different culture media].
    Tenorio-Abreu A; Eiros JM; Rodríguez-Molins E; Andaluz D; Bobillo F; Domínguez-Gil M; Ortiz de Lejarazu R
    Rev Esp Quimioter; 2010 Jun; 23(2):76-80. PubMed ID: 20559605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control.
    Brown SD; Traczewski MM
    J Clin Microbiol; 2007 Jul; 45(7):2173-9. PubMed ID: 17494717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in determining in vitro tigecycline susceptibility according to the agar medium used.
    Leal AL; Buitrago G; Ovalle MV; Cortés JA; Alvarez CA; Larrota J;
    J Chemother; 2010 Apr; 22(2):137-8. PubMed ID: 20435576
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of manganese in test media on in vitro susceptibility of Enterobacteriaceae and Acinetobacter baumannii to tigecycline.
    Veenemans J; Mouton JW; Kluytmans JA; Donnely R; Verhulst C; van Keulen PH
    J Clin Microbiol; 2012 Sep; 50(9):3077-9. PubMed ID: 22718943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method.
    Bradford PA; Petersen PJ; Young M; Jones CH; Tischler M; O'Connell J
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3903-9. PubMed ID: 16127069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of testing methodology on the tigecycline activity profile against presumably tigecycline-non-susceptible Acinetobacter spp.
    Casal M; Rodríguez F; Johnson B; Garduno E; Tubau F; de Lejarazu RO; Tenorio A; Giménez MJ; Bartolomé R; Garcia-Rey C; Aguilar L; García-Escribano N
    J Antimicrob Chemother; 2009 Jul; 64(1):69-72. PubMed ID: 19451133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline.
    Babaei S; Haeili M
    BMC Infect Dis; 2021 Jul; 21(1):709. PubMed ID: 34315422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of tigecycline against clinical isolates from Shanghai, China.
    Zhang YY; Zhou L; Zhu DM; Wu PC; Hu FP; Wu WH; Wang F
    Diagn Microbiol Infect Dis; 2004 Dec; 50(4):267-81. PubMed ID: 15582300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of medium age and supplementation with the biocatalytic oxygen-reducing reagent oxyrase on in vitro activities of tigecycline against recent clinical isolates.
    Petersen PJ; Bradford PA
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3910-8. PubMed ID: 16127070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.